Overview

A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials

Status:
Recruiting
Trial end date:
2029-07-15
Target enrollment:
Participant gender:
Summary
The main objectives of this study are to evaluate the long-term safety of spesolimab in patients with perianal fistulising Crohn's disease who have completed treatment in parent trials and to evaluate the long-term efficacy of spesolimab in patients with perianal fistulising Crohn's disease, who have completed treatment in parent trials
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim